Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen
Cancer, 09/18/08
Singer EA et al. - In a study to determine the precise correlation between oral nonsteroidal anti-inflammatory drugs (NSAIDs) use, serum prostate-specific antigen (PSA), and prostate cancer risk, it was found that regular NSAID consumption may reduce serum PSA levels. Whether this is indicative of a protective effect on prostate cancer risk or masks possible prostate injury resulting in reduced detection of prostate cancer is unclear
Methods- PSA levels were determined in 1319 men aged >40 years in the 2001-2002 National Health and Nutrition Examination Survey
- Linear regressions were performed on log-transformed PSA levels to evaluate the relations between PSA and the use of NSAIDs and acetaminophen after adjusting for effects of age, race, educational level, smoking status, body mass index, coexisting inflammatory conditions, and heart disease
- NSAID and acetaminophen consumption displayed a negative association with PSA levels, namely, individuals who reported using NSAIDs (19.8%) or acetaminophen (1.3%) regularly had lower PSA levels than individuals who did not take these drugs, although the impact of acetaminophen was not statistically significant
- PSA levels among NSAID users were 0.9 times the levels among nondrug takers; PSA levels among acetaminophen users were 0.76 times the levels in nondrug takers
- Individuals who said they took both NSAIDs and acetaminophen regularly had higher PSA levels, although not statistically significantly so, than individuals who stated they did not take either of these drugs regularly
Related Articles
Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels
International Braz J Urol, 11/06/09
Relevance Score: 80%
Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r
Magnetic Resonance in Medicine, 10/09/09
Relevance Score: 80%
Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence
Journal of Clinical Oncology, 11/02/09
Relevance Score: 79%
Relationship Between Prostate-specific Antigen and Hematocrit: Does Hemodilution Lead to Lower PSA Concentrations in Men With a Higher Body Mass Index
Urology, 10/28/09
Relevance Score: 79%
Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4–10 ng/mL and disease prognostication after radical prostatectomy
BJU International, 10/14/09
Relevance Score: 79%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of Methylphenidate on Cerebral Glucose Metabolism in Patients With Impaired Consciousness After Acquired Brain Injury
Clinical Neuropharmacology, 12/05/09
Gabapentin Enacarbil in Restless Legs Syndrome: A Phase 2b, 2-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Clinical Neuropharmacology, 12/05/09
Inhibition of long-term potentiation by valproic acid through modulation of cyclic AMP
Epilepsia, 12/05/09
Today in Over The Counter (OTC)...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of free radicals in liver diseases
Hepatology International, 12/02/09
Continuation of Low-Dose Aspirin in Peptic Ulcer Bleeding. A Randomized Trial
Annals of Internal Medicine, 12/01/09
Two cases of wheat-dependent anaphylaxis induced by aspirin administration but not by exercise
Clinical and Experimental Dermatology, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


